173 related articles for article (PubMed ID: 34314645)
1. Epidemiology of Idiopathic Pulmonary Fibrosis among U.S. Veterans, 2010-2019.
Kaul B; Lee JS; Zhang N; Vittinghoff E; Sarmiento K; Collard HR; Whooley MA
Ann Am Thorac Soc; 2022 Feb; 19(2):196-203. PubMed ID: 34314645
[No Abstract] [Full Text] [Related]
2. Disparities in Antifibrotic Medication Utilization Among Veterans With Idiopathic Pulmonary Fibrosis.
Kaul B; Lee JS; Petersen LA; McCulloch C; Rosas IO; Bandi VD; Zhang N; DeDent AM; Collard HR; Whooley MA
Chest; 2023 Aug; 164(2):441-449. PubMed ID: 36801465
[TBL] [Abstract][Full Text] [Related]
3. Agent Orange Exposure and Risk of Idiopathic Pulmonary Fibrosis among U.S. Veterans.
Kaul B; Lee JS; Glidden DV; Blanc PD; Zhang N; Collard HR; Whooley MA
Am J Respir Crit Care Med; 2022 Sep; 206(6):750-757. PubMed ID: 35559726
[No Abstract] [Full Text] [Related]
4. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.
Harari S; Davì M; Biffi A; Caminati A; Ghirardini A; Lovato V; Cricelli C; Lapi F
Intern Emerg Med; 2020 Apr; 15(3):437-445. PubMed ID: 31541394
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
Nalysnyk L; Cid-Ruzafa J; Rotella P; Esser D
Eur Respir Rev; 2012 Dec; 21(126):355-61. PubMed ID: 23204124
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019.
Seedahmed MI; Baugh AD; Albirair MT; Luo Y; Chen J; McCulloch CE; Whooley MA; Koth LL; Arjomandi M
Ann Am Thorac Soc; 2023 Jun; 20(6):797-806. PubMed ID: 36724377
[No Abstract] [Full Text] [Related]
7. Global incidence and prevalence of idiopathic pulmonary fibrosis.
Maher TM; Bendstrup E; Dron L; Langley J; Smith G; Khalid JM; Patel H; Kreuter M
Respir Res; 2021 Jul; 22(1):197. PubMed ID: 34233665
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
Esposito DB; Lanes S; Donneyong M; Holick CN; Lasky JA; Lederer D; Nathan SD; O'Quinn S; Parker J; Tran TN
Am J Respir Crit Care Med; 2015 Nov; 192(10):1200-7. PubMed ID: 26241562
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.
Harari S; Madotto F; Caminati A; Conti S; Cesana G
PLoS One; 2016; 11(2):e0147072. PubMed ID: 26841042
[TBL] [Abstract][Full Text] [Related]
10. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
Gupta R; Morgan AD; George PM; Quint JK
Thorax; 2024 Jun; 79(7):624-631. PubMed ID: 38688708
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.
Lee HE; Myong JP; Kim HR; Rhee CK; Yoon HK; Koo JW
Int J Tuberc Lung Dis; 2016 Jul; 20(7):978-84. PubMed ID: 27287654
[TBL] [Abstract][Full Text] [Related]
12. Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and Improvement.
Ley B; Urbania T; Husson G; Vittinghoff E; Brush DR; Eisner MD; Iribarren C; Collard HR
Ann Am Thorac Soc; 2017 Jun; 14(6):880-887. PubMed ID: 28355518
[TBL] [Abstract][Full Text] [Related]
13. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Raghu G; Chen SY; Hou Q; Yeh WS; Collard HR
Eur Respir J; 2016 Jul; 48(1):179-86. PubMed ID: 27126689
[TBL] [Abstract][Full Text] [Related]
14. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Fernández Pérez ER; Daniels CE; Schroeder DR; St Sauver J; Hartman TE; Bartholmai BJ; Yi ES; Ryu JH
Chest; 2010 Jan; 137(1):129-37. PubMed ID: 19749005
[TBL] [Abstract][Full Text] [Related]
15. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
16. Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.
Singer D; Bengtson LGS; Conoscenti CS; Laouri M; Shetty SS; Anderson AJ; Brown KK
Ann Am Thorac Soc; 2022 Jul; 19(7):1112-1121. PubMed ID: 35015982
[No Abstract] [Full Text] [Related]
17. Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada.
Hopkins RB; Burke N; Fell C; Dion G; Kolb M
Eur Respir J; 2016 Jul; 48(1):187-95. PubMed ID: 27230442
[TBL] [Abstract][Full Text] [Related]
18. Risk of cancer incidence in patients with idiopathic pulmonary fibrosis: A nationwide cohort study.
Lee HY; Lee J; Lee CH; Han K; Choi SM
Respirology; 2021 Feb; 26(2):180-187. PubMed ID: 33145926
[TBL] [Abstract][Full Text] [Related]
19. The rising incidence of idiopathic pulmonary fibrosis in the U.K.
Navaratnam V; Fleming KM; West J; Smith CJ; Jenkins RG; Fogarty A; Hubbard RB
Thorax; 2011 Jun; 66(6):462-7. PubMed ID: 21525528
[TBL] [Abstract][Full Text] [Related]
20. Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study.
Koteci A; Morgan AD; Portas L; Whittaker HR; Kallis C; George PM; Quint JK
BMC Pulm Med; 2022 May; 22(1):190. PubMed ID: 35549901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
